{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:49:12Z","timestamp":1780555752006,"version":"3.54.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.semarthrit.2006.07.001","type":"journal-article","created":{"date-parts":[[2006,9,13]],"date-time":"2006-09-13T07:16:35Z","timestamp":1158131795000},"page":"144-152","source":"Crossref","is-referenced-by-count":86,"title":["Pathogenesis and Management of Adult-Onset Still\u2019s Disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Petros","family":"Efthimiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Georgy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.semarthrit.2006.07.001_bib1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/ard.2005.042143","article-title":"Diagnosis and management of adult onset Still\u2019s disease","volume":"65","author":"Efthimiou","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2006.07.001_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.30.2.121","article-title":"Still\u2019s disease in the adult","volume":"30","author":"Bywaters","year":"1971","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2006.07.001_bib3","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0140-6736(01)61263-7","article-title":"Rheumatoid Arthritis: its clinical history, etiology and pathology","volume":"1","author":"Bannatyne","year":"1896","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.semarthrit.2006.07.001_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0950-3579(05)80283-3","article-title":"Adult-onset Still\u2019s disease","volume":"5","author":"van de Putte","year":"1991","journal-title":"Baillieres Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2006.07.001_bib5","first-page":"1139","article-title":"Adult Still\u2019s disease: review of 228 cases from the literature","volume":"14","author":"Ohta","year":"1987","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2006.07.001_bib6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still\u2019s disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.semarthrit.2006.07.001_bib7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.berh.2004.05.004","article-title":"Adult-onset Still\u2019s disease","volume":"18","author":"Kadar","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2006.07.001_bib8","first-page":"1058","article-title":"Adult Still\u2019s disease: a multicenter survey of Japanese patients","volume":"17","author":"Ohta","year":"1990","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2006.07.001_bib9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/ard.59.6.490c","article-title":"Rubella infection in adult onset Still\u2019s disease","volume":"59","author":"Escudero","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2006.07.001_bib10","doi-asserted-by":"crossref","first-page":"E105","DOI":"10.1086\/319342","article-title":"Adult Still\u2019s disease associated with Mycoplasma pneumoniae infection","volume":"32","author":"Perez","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2006.07.001_bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/art.1780290316","article-title":"Adult-onset Still\u2019s disease","volume":"29","author":"Wouters","year":"1986","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2006.07.001_bib12","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/art.1780241203","article-title":"HLA-Bw35 and prognosis in adult Still\u2019s disease","volume":"24","author":"Terkeltaub","year":"1981","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2006.07.001_bib13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/art.1780280207","article-title":"HLA gene frequencies in children and adults with systemic onset juvenile rheumatoid arthritis","volume":"28","author":"Miller","year":"1985","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2006.07.001_bib14","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/rheumatology\/40.12.1398","article-title":"Cytokine and immunogenetic profiles in Japanese patients with adult Still\u2019s disease","volume":"40","author":"Fujii","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.semarthrit.2006.07.001_bib15","first-page":"489","article-title":"Association between HLA-DR B1 and clinical features of adult onset Still\u2019s disease in Korea","volume":"21","author":"Joung","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2006.07.001_bib16","first-page":"396","article-title":"Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still\u2019s disease","volume":"25","author":"Hoshino","year":"1998","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2006.07.001_bib17","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/ard.2003.013680","article-title":"Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still\u2019s disease","volume":"63","author":"Chen","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2006.07.001_bib18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/art.20946","article-title":"Targeting the interleukin-6 receptor: a new treatment for systemic juvenile idiopathic arthritis?","volume":"52","author":"de Benedetti","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2006.07.001_bib19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/rheumatology\/38.5.477","article-title":"High serum level of macrophage-colony stimulating factor (M-CSF) in adult-onset Still\u2019s disease","volume":"38","author":"Matsui","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.semarthrit.2006.07.001_bib20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1529-0131(200103)44:3<550::AID-ANR103>3.0.CO;2-5","article-title":"Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still\u2019s disease","volume":"44","author":"Kawashima","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.semarthrit.2006.07.001_bib21","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/sj.gene.6363922","article-title":"Association between adult-onset Still\u2019s disease and interleukin-18 gene polymorphisms","volume":"3","author":"Sugiura","year":"2002","journal-title":"Genes Immun"},{"issue":"6552","key":"10.1016\/j.semarthrit.2006.07.001_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/378088a0","article-title":"Cloning of a new cytokine that induces IFN-gamma production by T cells","volume":"378","author":"Okamura","year":"1995","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.semarthrit.2006.07.001_bib23","first-page":"673","article-title":"Hepatic abnormalities in adult onset Still\u2019s disease","volume":"6","author":"Esdaile","year":"1979","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2006.07.001_bib24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1034\/j.1600-0528.2002.017418.x","article-title":"Pathophysiological roles of interleukin-18 in inflammatory liver diseases","volume":"174","author":"Tsutsui","year":"2000","journal-title":"Immunol Rev"},{"issue":"3","key":"10.1016\/j.semarthrit.2006.07.001_bib25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/intimm\/11.3.471","article-title":"IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock","volume":"11","author":"Sakao","year":"1999","journal-title":"Int Immunol"},{"issue":"6","key":"10.1016\/j.semarthrit.2006.07.001_bib26","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/art.20268","article-title":"Increased interleukin-18 expression in bone marrow of a patient with systemic juvenile idiopathic arthritis and unrecognized macrophage-activation syndrome","volume":"50","author":"Maeno","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.semarthrit.2006.07.001_bib27","first-page":"2189","article-title":"Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still\u2019s disease","volume":"31","author":"Chen","year":"2004","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2006.07.001_bib28","first-page":"1093","article-title":"Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still\u2019s disease","volume":"30","author":"Ogata","year":"2003","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2006.07.001_bib29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/art.21164","article-title":"Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still\u2019s disease","volume":"53","author":"Chen","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2006.07.001_bib30","first-page":"124","article-title":"TCR gamma delta + T cells in peripheral blood of patients with adult Still\u2019s disease","volume":"23","author":"Hoshino","year":"1996","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2006.07.001_bib31","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/art.1780250607","article-title":"Adult-onset Still\u2019s disease","volume":"25","author":"Elkon","year":"1982","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2006.07.001_bib32","first-page":"405","article-title":"Cutaneous vasculitis associated with mixed cryoglobulinemia in adult Still\u2019s disease","volume":"21","author":"Elezoglou","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2006.07.001_bib33","doi-asserted-by":"crossref","first-page":"R616","DOI":"10.1186\/ar1721","article-title":"Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still\u2019s disease: use in the differential diagnosis of hyperferritinemia","volume":"7","author":"Kirino","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.semarthrit.2006.07.001_bib34","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J Exp Med"},{"issue":"suppl 12","key":"10.1016\/j.semarthrit.2006.07.001_bib35","doi-asserted-by":"crossref","first-page":"S460","DOI":"10.1097\/01.CCM.0000185500.11080.91","article-title":"Interleukin-1beta","volume":"33","author":"Dinarello","year":"2005","journal-title":"Crit Care Med"},{"issue":"15","key":"10.1016\/j.semarthrit.2006.07.001_bib36","doi-asserted-by":"crossref","first-page":"R581","DOI":"10.1016\/j.cub.2005.07.049","article-title":"The inflammasome","volume":"15","author":"Petrilli","year":"2005","journal-title":"Curr Biol"},{"issue":"9","key":"10.1016\/j.semarthrit.2006.07.001_bib37","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1084\/jem.20050640","article-title":"Blocking IL-1 in systemic inflammation","volume":"201","author":"Dinarello","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.semarthrit.2006.07.001_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2005.046904","article-title":"Reactive haemophagocytic syndrome in adult onset Still\u2019s disease: report of 6 patients and review of the literature","author":"Arlet","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2006.07.001_bib39","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00002281-200309000-00011","article-title":"Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities?","volume":"15","author":"Grom","year":"2003","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2006.07.001_bib40","first-page":"100","article-title":"Cytomegalovirus-associated hemophagocytic syndrome in a patient with adult onset Still\u2019s disease","volume":"23","author":"Amenomori","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2006.07.001_bib41","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar1453","article-title":"Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome","volume":"7","author":"Villanueva","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.semarthrit.2006.07.001_bib42","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1067\/mpd.2003.110","article-title":"Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome","volume":"142","author":"Grom","year":"2003","journal-title":"J Pediatr"},{"issue":"11","key":"10.1016\/j.semarthrit.2006.07.001_bib43","first-page":"758","article-title":"Adult Still\u2019s disease","volume":"62","author":"Masson","year":"1995","journal-title":"Rev Rhum Engl Ed"},{"issue":"235","key":"10.1016\/j.semarthrit.2006.07.001_bib44","first-page":"1055","article-title":"Adult-onset Still\u2019s disease; clinical and laboratory features, treatment and progress of 45 cases","volume":"61","author":"Wouters","year":"1986","journal-title":"Q J Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2006.07.001_bib45","first-page":"1","article-title":"Adult-onset Still\u2019s disease","volume":"49","author":"Cush","year":"2000","journal-title":"Bull Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2006.07.001_bib46","first-page":"495","article-title":"Comparative study of 6 types of criteria in adult Still\u2019s disease","volume":"23","author":"Masson","year":"1996","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2006.07.001_bib47","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0049-0172(87)90015-1","article-title":"Adult onset Still\u2019s disease: experience in 23 patients and literature review with emphasis on organ failure","volume":"17","author":"Reginato","year":"1987","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2006.07.001_bib48","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/030097400447624","article-title":"Treatment of adult Still\u2019s disease with dexamethasone, an alternative to prednisolone","volume":"29","author":"Koizumi","year":"2000","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2006.07.001_bib49","first-page":"1088","article-title":"Treatment of fulminant adult Still\u2019s disease with intravenous pulse methylprednisolone therapy","volume":"18","author":"Khraishi","year":"1991","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2006.07.001_bib50","first-page":"1391","article-title":"Cyclosporin A in the treatment of adult Still\u2019s disease","volume":"22","author":"Shojania","year":"1995","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2006.07.001_bib51","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/art.1780300209","article-title":"Adult-onset Still\u2019s disease","volume":"30","author":"Cush","year":"1987","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2006.07.001_bib52","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00005792-198403000-00002","article-title":"Adult Still\u2019s disease","volume":"63","author":"Larson","year":"1984","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.semarthrit.2006.07.001_bib53","first-page":"791","article-title":"Adult onset Still\u2019s disease in the elderly: a report of two cases","volume":"12","author":"Wouters","year":"1985","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2006.07.001_bib54","first-page":"373","article-title":"Corticosteroid sparing effect of low dose methotrexate treatment in adult Still\u2019s disease","volume":"26","author":"Fautrel","year":"1999","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2006.07.001_bib55","first-page":"431","article-title":"Low dose methotrexate treatment in adult Still\u2019s disease","volume":"19","author":"Aydintug","year":"1992","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2006.07.001_bib56","first-page":"2067","article-title":"Intravenous immunoglobulin in the treatment of refractory adult Still\u2019s disease","volume":"26","author":"Mahmud","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2006.07.001_bib57","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0248-8663(96)80703-X","article-title":"Treatment of Still disease in adults with intravenous immunoglobulins","volume":"16","author":"Permal","year":"1995","journal-title":"Rev Med Interne"},{"issue":"3","key":"10.1016\/j.semarthrit.2006.07.001_bib58","first-page":"295","article-title":"Intravenous immunoglobulin in adult Still\u2019s disease refractory to non-steroidal anti-inflammatory drugs","volume":"16","author":"Vignes","year":"1998","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2006.07.001_bib59","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1345\/aph.1E425","article-title":"Leflunomide and azathioprine combination in refractory adult-onset Still\u2019s disease","volume":"39","author":"Cefle","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.semarthrit.2006.07.001_bib60","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/rheumatology\/keh172","article-title":"Adult onset Still\u2019s disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil","volume":"43","author":"Bennett","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.semarthrit.2006.07.001_bib61","first-page":"733","article-title":"Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still\u2019s disease: the first case report","volume":"23","author":"Benucci","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2006.07.001_bib62","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/ard.61.9.859-a","article-title":"Adult onset Still\u2019s disease: response to Enbrel","volume":"61","author":"Asherson","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2006.07.001_bib63","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/art.10231","article-title":"Etanercept in the treatment of adult patients with Still\u2019s disease","volume":"46","author":"Husni","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.semarthrit.2006.07.001_bib64","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.amjmed.2003.04.001","article-title":"Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still\u2019s disease","volume":"115","author":"Serratrice","year":"2003","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2006.07.001_bib65","first-page":"329","article-title":"Infliximab in the treatment of adult Still\u2019s disease refractory to conventional therapy","volume":"19","author":"Cavagna","year":"2001","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2006.07.001_bib66","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.rhu.0000135618.25723.16","article-title":"Treatment of resistant adult Still\u2019s disease with Infliximab: a report of 2 cases","volume":"10","author":"Huffstutter","year":"2004","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2006.07.001_bib67","first-page":"23","article-title":"[Infliximab (anti-TNF-alpha) treatment in patients with adult Still\u2019s disease. Experience in 2 cases]","volume":"21","author":"Bonilla Hernan","year":"2004","journal-title":"An Med Interna"},{"issue":"1","key":"10.1016\/j.semarthrit.2006.07.001_bib68","first-page":"113","article-title":"A case of adult onset Still\u2019s disease treated with infliximab","volume":"20","author":"Caramaschi","year":"2002","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2006.07.001_bib69","first-page":"121","article-title":"Prolonged efficacy of infliximab for refractory adult-onset Still\u2019s disease","volume":"23","author":"Dilhuydy","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"4-5","key":"10.1016\/j.semarthrit.2006.07.001_bib70","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10067-003-0744-z","article-title":"Infliximab in a case of early adult-onset Still\u2019s disease","volume":"22","author":"Olivieri","year":"2003","journal-title":"Clin Rheumatol"},{"issue":"23","key":"10.1016\/j.semarthrit.2006.07.001_bib71","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1055\/s-2004-826865","article-title":"[Longterm outcome of TNF blockade in adult-onset Still\u2019s disease]","volume":"129","author":"Dechant","year":"2004","journal-title":"Dtsch Med Wochenschr"},{"issue":"1","key":"10.1016\/j.semarthrit.2006.07.001_bib72","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10067-003-0775-5","article-title":"Successful treatment of refractory adult-onset Still\u2019s disease with infliximab","volume":"23","author":"Kokkinos","year":"2004","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2006.07.001_bib73","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/ard.2004.024026","article-title":"Tumour necrosis factor alpha blocking agents in refractory adult Still\u2019s disease: an observational study of 20 cases","volume":"64","author":"Fautrel","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2006.07.001_bib74","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","article-title":"Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type","volume":"48","author":"Quartier","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2006.07.001_bib75","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/ard.2003.014886","article-title":"The German etanercept registry for treatment of juvenile idiopathic arthritis","volume":"63","author":"Horneff","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2006.07.001_bib76","doi-asserted-by":"crossref","unstructured":"Klausner JD, Freedman VH, Kaplan G. Thalidomide as an anti-TNF-alpha inhibitor: implications for clinical use. Clin Immunol Immunopathol 81(3):219-23.","DOI":"10.1006\/clin.1996.0181"},{"issue":"5","key":"10.1016\/j.semarthrit.2006.07.001_bib77","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/107327480301000504","article-title":"Thalidomide and its derivatives: new promise for multiple myeloma","volume":"10","author":"Weber","year":"2003","journal-title":"Cancer Control"},{"issue":"6","key":"10.1016\/j.semarthrit.2006.07.001_bib78","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jpeds.2004.08.020","article-title":"Thalidomide for severe systemic onset juvenile rheumatoid arthritis: a multicenter study","volume":"145","author":"Lehman","year":"2004","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.semarthrit.2006.07.001_bib79","first-page":"272","article-title":"Efficacy of thalidomide in refractory adult Still\u2019s disease: a new case report","volume":"21","author":"Meaux-Ruault","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"9127","key":"10.1016\/j.semarthrit.2006.07.001_bib80","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0140-6736(05)79252-7","article-title":"TNFalpha and response of treatment-resistant adult-onset Still\u2019s disease to thalidomide","volume":"352","author":"Stambe","year":"1998","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.semarthrit.2006.07.001_bib81","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/art.20944","article-title":"Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis","volume":"52","author":"Yokota","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2006.07.001_bib82","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/art.10620","article-title":"Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still\u2019s disease","volume":"46","author":"Iwamoto","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2006.07.001_bib83","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/ard.2004.026617","article-title":"Refractory adult onset Still\u2019s disease successfully treated with anakinra","volume":"64","author":"Godinho","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"suppl","key":"10.1016\/j.semarthrit.2006.07.001_bib84","first-page":"281","article-title":"Prompt response to treatment with anakinra in adult onset Still\u2019s disease","volume":"63","author":"Aelion","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"suppl","key":"10.1016\/j.semarthrit.2006.07.001_bib85","first-page":"293","article-title":"Anakinra in the treatment of adult onset Still\u2019s disease","volume":"63","author":"Haraoui","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2006.07.001_bib86","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/art.21061","article-title":"Rapid responses to anakinra in patients with refractory adult-onset Still\u2019s disease","volume":"52","author":"Fitzgerald","year":"2005","journal-title":"Arthritis Rheum"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017206000953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017206000953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T00:20:45Z","timestamp":1555806045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017206000953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0049017206000953"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2006.07.001","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}